ACR 2018 Podcast - Day 2B

Save

Audio Highlights and Interviews from Day 2 at the ACR 2018 meeting - LISTE

ACR 2018 - Day 2 Report

Save

Monday was a packed day of sessions and studies. Here are our just a few of our highlights.

ACR 2018 Podcast - Day 1B

Save

Audio Highlights and Interviews from Day 1 at the ACR 2018 meeting - LISTEN HERE

ACR 2018 Podcast - Day 2A

Save

Audio Highlights and Interviews from Day 2 at the ACR 2018 meeting - LISTEN HERE

Technology Tools for the Rheumatologist

Save

Four years ago, the genesis of this session (technology tools for rheumatologists) was from the frustration of the archaic technologies we have been using in our medical practices (including user hostile EHRs), compared to the rapid advancing pace of the consumer technologies we use at home. So came the struggle to adapt affordable and usable consumer technology products in the office that would save time (or at least be time neutral) and impact patient management.

Is DAS28 and HAQ-DI Headed for the Graveyard?

Save

Dr. Joseph Smolen delivered one of the most elegant and informative talk on rheumatoid arthritis at this ACR’s meeting as a tribute to Dr. Paul Klemperer. Dr. Smolen led us on a journey, and had us feeling content with what we are doing in practice as we walked with him from historical discoveries of RA through new drug development. Then Dr. Smolen did the unthinkable: he made us crash!

ACR 2018 Podcast - Day 1A

Save

Check out the first part of our Day 1 Podcast from ACR 2018 - LISTEN HERE

Several Studies Addressed Treatment of Axial Spondylitis

Save

Monday afternoon's session on the treatment of Axial Spondyloarthritis presented us with a great selection of studies addressing important issues in modern treatment paradigm of AxSpA.

TRIPLE Trial Results

Save

Pegloticase has become an excellent option for management of patients with chronic refractory gout, although treatment may be limited by the development of anti-drug antibodies that lead to loss of serum urate (sUA) lowering effect.

Emerging Trends in the Treatment of Rheumatoid Arthritis

Save

Factors That Contribute to Uveitis in SpA

Save

We know that uveitis is an extra-articular manifestation of SpA but what remains unclear is if there are any factors that may play a role in the development of uveitis. One group sought to understand these issues.

ACR 2018 - Day 1 Report

Save

RheumNow is in Chicago covering the ACR annual meeting. Here are the highlights from Sunday (day one). Be sure to check our complete coverage, including articles, video reports and tweets, at acr18.rheumnow.com.

Gout and the Social Determinants of Health

Save

During a fascinating gout session on October 21, Hyon Choi presented an important paper (abstract 874) which used data from the Health Professionals Follow-up Study to try to understand the rapid increase in the incidence of gout in recent decades.

Because It's Rare Doesn’t Mean It Doesn’t Exist: A Tribute to Relapsing Polychondritis

Save

During medical training, we were taught about rare diseases that are unlikely to be encountered, but there is a reason why our professors even mention these diseases. It is not just for our board exams; the lectures are for us to recognize the features of the disease when the rare patient comes across our exam table.